Pure Global

Evaluation of Breast Cancer Screening Program at Assiut Governorate - Trial NCT06403917

Access comprehensive clinical trial information for NCT06403917 through Pure Global AI's free database. This phase not specified trial is sponsored by Assiut University and is currently Not yet recruiting. The study focuses on Breast Cancer. Target enrollment is 15000000 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT06403917
Not yet recruiting
other
Trial Details
ClinicalTrials.gov โ€ข NCT06403917
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Evaluation of Breast Cancer Screening Program at Assiut Governorate
Evaluation of Breast Cancer Screening Program in Assiut Governorate Egyptian Women Health Initiative

Study Focus

Breast Cancer

Evaluation of breast screening

Observational

other

Sponsor & Location

Assiut University

Timeline & Enrollment

N/A

Jun 01, 2024

May 30, 2025

15000000 participants

Primary Outcome

1-To evaluate the ability of breast clinical examination as screening tool to detect early and advanced stages of breast cancer.

Summary

1. To evaluate the ability of breast clinical examination as screening tool to detect early
 and advanced stages of breast cancer.
 
 2. To determine the percentage of breast cancer confirmed cases among women screened at
 women health campaign in Assiut governorate.
 
 3. To determine drop out from referral system among screening program.
 
 4. Identify the healthcare providers knowledge about breast cancer and screening tools,
 perception, practice and barriers in delivering the program

ICD-10 Classifications

Malignant neoplasm of breast
Malignant neoplasm of breast
Carcinoma in situ of breast, unspecified
Malignant neoplasm: Breast, unspecified
Other carcinoma in situ of breast

Data Source

ClinicalTrials.gov

NCT06403917

Non-Device Trial